Future Procurement Opportunity (FPO) – Supply of budesonide/eformoterol dry powder inhalers (DPIs)

Details

Tender Closed
RFx ID :	24479707
Tender Name :	Future Procurement Opportunity (FPO) – Supply of budesonide/eformoterol dry powder inhalers (DPIs)
Reference # :	A1504861
Open Date :	Q2 2021
Indicative RFx Release Date  :	Q4 2021  [?]
Tender Type :	Future Procurement Opportunity (FPO)
Project Status :	Initial development  [?]
Indicative Total Value :	$50M - $100M  [?]
Expected number of contracts offered :	1
Tender Coverage :	Sole Agency  [?]
Categories :	51000000 - Drugs and Pharmaceutical Products
Regions:	New Zealand
Required Pre-qualifications :	None
Contact :	PHARMAC Procurement Team procurement@Pharmac.govt.nz
Agency Address :

PHARMAC is planning on issuing a competitive process for supply of budesonide/eformoterol dry powder inhalers (DPIs).

The approximate annual gross expenditure of budesonide/eformoterol DPIs in the 2020 FYR was $25,000,000. For current funding information please view the Pharmaceutical Schedule: https://www.pharmac.govt.nz/tools-resources/pharmaceutical-schedule/community/

This tender has been completed.

Date RFx was completed/updated: Thursday, 4 May 2023 4:05 PM (Pacific/Auckland UTC+12:00)